Related Experiment Video
Updated: Jun 26, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Association of v-ErbA with Smad4 disrupts TGF-beta signaling
Richard A Erickson1, Xuedong Liu
1Department of Chemistry and Biochemistry, University of Colorado-Boulder, Boulder, CO 80309, USA.
Abstract:
Disruption of the transforming growth factor-beta (TGF-beta) pathway is observed in the majority of cancers. To further understand TGF-beta pathway inactivation in cancer, we stably expressed the v-ErbA oncoprotein in TGF-beta responsive cells. v-ErbA participates in erythroleukemic transformation of cells induced by the avian erythroblastosis virus (AEV). Here we demonstrate that expression of v-ErbA was sufficient to antagonize TGF-beta-induced cell growth inhibition and that dysregulation of TGF-beta signaling required that v-ErbA associate with the Smad4 which sequesters Smad4 in the cytoplasm. We also show that AEV-transformed erythroleukemia cells were resistant to TGF-beta-induced growth inhibition and that TGF-beta sensitivity could be recovered by reducing v-ErbA expression. Our results reveal a novel mechanism for oncogenic disruption of TGF-beta signaling and provide a mechanistic explanation of v-ErbA activity in AEV-induced erythroleukemia.
Insights
The v-ErbA oncoprotein disrupts the transforming growth factor-beta (TGF-beta) pathway in cancer by sequestering Smad4, inhibiting TGF-beta
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor-beta (TGF-beta) pathway dysregulation is common in many cancers.
- Understanding mechanisms of TGF-beta pathway inactivation is crucial for cancer research.
Purpose of the Study:
- To investigate how the v-ErbA oncoprotein disrupts TGF-beta signaling in cancer.
- To elucidate the role of v-ErbA in TGF-beta pathway inactivation.
Main Methods:
- Stable expression of v-ErbA oncoprotein in TGF-beta responsive cells.
- Analysis of TGF-beta signaling components, including Smad4 localization.
- Assessment of cellular response to TGF-beta in v-ErbA expressing cells and avian erythroblastosis virus (AEV)-transformed cells.
Main Results:
- v-ErbA expression antagonized TGF-beta-induced cell growth inhibition.
- v-ErbA associated with Smad4, leading to its cytoplasmic sequestration and dysregulation of TGF-beta signaling.
- AEV-transformed erythroleukemia cells exhibited resistance to TGF-beta, which was reversible by reducing v-ErbA levels.
Conclusions:
- v-ErbA employs a novel mechanism to oncogenically disrupt TGF-beta signaling.
- Smad4 sequestration by v-ErbA provides a mechanistic explanation for v-ErbA's activity in AEV-induced erythroleukemia.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

